Chris Wagner

Biography

Chris Wagner has more than 25 years of experience in commercialization and product development in the life sciences industry. Mr. Wagner is currently the President & CEO of Contextual Genomics Inc, a molecular bioinformatics company enabling clinical laboratories worldwide to deliver complex genomic testing and automated clinical interpretation. Mr. Wagner recently served as President & CEO of Sirius Genomics Inc. Sirius Genomics developed personalized medicines for critical care illness. The company was sold to a strategic investor. Prior to Sirius Genomics, Mr. Wagner was with Aspreva Pharmaceuticals as an officer, founding member of the company’s executive committee, and as Vice President of Business Development & Global Marketing. During his five-year tenure at Aspreva the valuation of the company was increased from $3 million to over $1 billion. Prior to Aspreva, Mr. Wagner was with Eli Lilly working in Europe, North America and Asia with positions based in Toronto, Indianapolis, and Boston. He worked on the development and commercialization of 15 products including biologics and small molecules with annual sales ranging from tens of millions to over $4 billion dollars per year.

Research Interest

Business Administration